Journal article
Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level.
- Abstract:
- The transcription factor FOXP3 plays a key role in CD4(+)CD25(+) regulatory T cell function and represents a specific marker for these cells. Despite its strong association with regulatory T cell function, in humans little is known about the frequency of CD4(+)CD25(+) cells that express FOXP3 protein nor the distribution of these cells in vivo. Here we report the characterization of seven anti-FOXP3 monoclonal antibodies enabling the detection of endogenous human FOXP3 protein by flow cytometry and immunohistochemistry. Flow-cytometric analysis showed that FOXP3 was expressed by the majority of CD4(+)CD25(high) T cells in peripheral blood. By contrast, less than half of the CD4(+)CD25(int) population were FOXP3(+), providing an explanation for observations in human T cells that regulatory activity is enriched within the CD4(+)CD25(high) pool. Although FOXP3 expression was primarily restricted to CD4(+)CD25(+) cells, it was induced following activation of both CD4(+) and CD8(+) T cell clones. These findings indicate that the frequency of FOXP3(+) cells correlates with the level of expression of CD25 in naturally arising regulatory T cells and that FOXP3 protein is expressed by some activated CD4(+) and CD8(+) T cell clones. These reagents represent valuable research tools to further investigate FOXP3 function and are applicable for routine clinical use.
- Publication status:
- Published
Actions
Authors
- Journal:
- European journal of immunology More from this journal
- Volume:
- 35
- Issue:
- 6
- Pages:
- 1681-1691
- Publication date:
- 2005-06-01
- DOI:
- EISSN:
-
1521-4141
- ISSN:
-
0014-2980
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:15991
- UUID:
-
uuid:df335feb-e3f8-4662-87b5-97914f49a380
- Local pid:
-
pubs:15991
- Source identifiers:
-
15991
- Deposit date:
-
2012-12-19
Terms of use
- Copyright date:
- 2005
If you are the owner of this record, you can report an update to it here: Report update to this record